Skip to main navigation Skip to search Skip to main content

Final results of phase III SYMMETRY study: Randomized, double-blind trial of elesclomol plus paclitaxel versus paclitaxel alone as treatment for chemotherapy-naive patients with advanced melanoma

  • Steven J. O'Day
  • , Alexander M.M. Eggermont
  • , Vanna Chiarion-Sileni
  • , Richard Kefford
  • , Jean Jacques Grob
  • , Laurent Mortier
  • , Caroline Robert
  • , Jacob Schachter
  • , Alessandro Testori
  • , Jacek Mackiewicz
  • , Philip Friedlander
  • , Claus Garbe
  • , Selma Ugurel
  • , Frances Collichio
  • , Wei Guo
  • , Joelle Lufkin
  • , Safi Bahcall
  • , Vojo Vukovic
  • , Axel Hauschild

Research output: Contribution to journal › Article › peer-review

309 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Final results of phase III SYMMETRY study: Randomized, double-blind trial of elesclomol plus paclitaxel versus paclitaxel alone as treatment for chemotherapy-naive patients with advanced melanoma'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases